TRIM24 and acute myeloid leukemia: To extend our findings in subcutaneously implanted AML xenograft models, the combination effects of T-3775440/pevonedistat were further evaluated in a mouse dissemination model using TF-1a-luc cells, in which leukemic cell growth was monitored noninvasively via emitted bioluminescence.